Monica Seles to help Shire ace marketing of new drug to treat binge-eating disorder

Analysts say that one of the biggest challenges Shire Pharmaceuticals will face in marketing the first-ever drug approved to treat binge-eating disorder is letting people know exactly what the disorder is. To that end, a partnership with former tennis star Monica Seles may help. Last week, Shire announced its top-selling drug for attention-deficit hyperactivity disorder, Vyvanse, had earned additional approval from the U.S. Food and Drug Administration to treat binge eating, which is recognized…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news